Lara Kujtan Selected Research

telisotuzumab vedotin

8/2023

Telisotuzumab vedotin with erlotinib in the treatment of non-small cell lung cancer: a well MET combination?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lara Kujtan Research Topics

Disease

5	Neoplasms (Cancer) 01/2023 - 01/2018
2	Lung Neoplasms (Lung Cancer) 10/2023 - 02/2022
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2023 - 01/2019
2	Carcinoma (Carcinomatosis) 01/2023 - 01/2018
1	Neoplasm Metastasis (Metastasis) 10/2023
1	Pericardial Effusion 10/2023
1	Colorectal Neoplasms (Colorectal Cancer) 10/2023
1	Abdominal Pain (Pain, Abdominal) 01/2023
1	Ovarian Neoplasms (Ovarian Cancer) 01/2023
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2023
1	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 05/2019
1	Prostatic Neoplasms (Prostate Cancer) 05/2019
1	Nasopharyngeal Carcinoma 01/2019
1	Chronic Disease (Chronic Diseases) 01/2019
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2018
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2018
1	Lymphoma (Lymphomas) 01/2018
1	Fabry Disease (Fabry's Disease) 01/2014

Drug/Important Bio-Agent (IBA)

2	Tyrosine Kinase InhibitorsIBA 10/2023 - 01/2019
2	ErbB Receptors (EGF Receptor)IBA 10/2023 - 01/2019
1	osimertinibIBA 10/2023
1	Cell-Free Nucleic AcidsIBA 10/2023
1	AntibodiesIBA 10/2023
1	telisotuzumab vedotinIBA 08/2023
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 08/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Immune Checkpoint InhibitorsIBA 02/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2019
1	Rituximab (Mabthera)FDA Link 05/2019
1	GalactosylgalactosylglucosylceramidaseIBA 01/2014
1	GalactosidasesIBA 01/2014
1	globotriaosylceramide (globotriosylceramide)IBA 01/2014

Therapy/Procedure

3	Therapeutics 05/2019 - 01/2018
3	Drug Therapy (Chemotherapy) 01/2019 - 01/2018
1	Adjuvant Chemotherapy 01/2023
1	Plasma Exchange 05/2019